Ujjal Dosanjh

[Wal-Mart, February 14th, 2005]

Mr. Speaker, there is no question that the issues around jobs for the people of Canada, including those of Quebec, is very important.

We in Health Canada believed that Wal-Mart was an appropriate business to deal with in terms of reaching thousands of people and in terms of an educational program that dealt with anti-smoking issues. However it is important to recognize that Health Canada is not an advertising agency for any business whatsoever.

[Health, February 14th, 2005]

Mr. Speaker, this is obviously a serious issue on which there is a significant divergence of scientific opinion. We will obviously take a look at this issue and then inform the House.

[Health, February 14th, 2005]

Mr. Speaker, the member has alluded to a serious problem. Health Canada is looking into the issue. I will be happy to inform the House once the deliberations of the department are over.

[Internet Pharmacies, February 9th, 2005]

Mr. Speaker, this development is just one more example of why we need to deal with protecting the pricing regime for Canadians and the affordable supply of drugs. We intend to do just that.

[Health, February 8th, 2005]

Mr. Speaker, I do not know what the hon. member has been listening to. The Canadian Medical Association supports what we are trying to do. The Ontario Pharmacists' Association today issued a press release supporting what we are trying to do to ensure there is good medicine, good ethical practices in Canada and that the supply is protected for Canadians at affordable prices.

[Health, February 8th, 2005]

Mr. Speaker, I am actually surprised the member is not embarrassed by the unethical and unprofessional practices that create bad medicine in Canada. It is important for us to remember that the Canadian pricing regime is for the good of all Canadians. Good medical ethics produce good medicine for all Canadians.

[Pharmaceutical Industry, February 7th, 2005]

Mr. Speaker, it is for that very reason, to protect good medicine based on good ethics and to protect the pricing regime that provides affordable drugs at affordable prices to all Canadians, that we shall be acting.

[Pharmaceutical Industry, February 7th, 2005]

Mr. Speaker, I have always said that we want to protect the pricing regime in the country. It is the member opposite who has had difficulty making up his mind.

On December 1, within the space of one minute, he said, first, that we must protect the value of pharmaceuticals to Canadians. Second, he said that we must heed the economic benefit of a new industry and the more than 4,000 job. Third, he said that export permits would be a good start. Fourth, he said that they were also bad because they could shut down the industry. Fifth, he said that we must be unequivocal.

It is time he make up his mind.

[Pharmaceutical Industry, February 7th, 2005]

Mr. Speaker, obviously it has been difficult for the members opposite to register some of my views on their minds.

The situation is the President of the Treasury Board and I have said very clearly that we want good medicine based on good ethics across the country, including in Manitoba. We will ensure that the medicine practice is conducted on the basis--

[Pharmaceutical Industry, February 7th, 2005]

Mr. Speaker, the fact is I have been speaking up on this issue for some time. The President of the Treasury Board and I are of one mind. What we have said--